Mark your calendars for the first Mosaic of Autoimmunity webinar – “Advancing Care: Breakthroughs in Diagnosing and Treating Ulcerative Colitis”!
This webinar is supported by an educational grant from Pfizer.
Objectives:
- Understand the pathophysiology, symptoms, and complications of Ulcerative Colitis, with a focus on its impact on young patients.
- Explore the latest advancements in UC management, including personalized medicine, biologic therapies, S1P receptor modulators, and JAK inhibitors, along with their mechanisms of action.
- Learn how to integrate new pharmacological treatments and lifestyle interventions into clinical practice while effectively communicating them to patients, carers, and parents.
Agenda:
- Introduction
- Understanding Ulcerative Colitis and Burden of Disease
The talk will delve into Ulcerative Colitis, discussing the pathophysiology, symptoms and complications with special emphasis on young patients. - Novel and Emerging UC treatments
The talk will address the latest therapeutic research and approaches in the management of UC, including personalized medicine, biologic therapies, emerging pharmacological agents (S1P Receptor Modulators & JAK Inhibitors) and their MoA. - Integration into clinical practice
The talk will delve into how to effectively integrate pharmacological treatments into practice and examine which key lifestyle interventions doctors should explore with their patients. It will also cover how to effectively communicate them to carers/parents and young patients. - Conclusion
Final Q&A and live evaluation survey on effectiveness of content.
Faculty
Dr. Ayal Hirsch
Gastroenterologist
Prof. Uri Kopylov
Director of inflammatory bowel disease, IBD clinic
Prof. Uri Kopylov, MD, MBA is a Director of inflammatory bowel disease (IBD) clinic. He has an extensive research record in IBD and endoscopy, with multiple international collaborations and over 260 peer-reviewed publications. Prof. Kopylov is the secretary of the Israeli IBD society and the member of the Educational Committee of the European Crohn’s and Colitis Organization. He is a co-director of the Innovation Center in Gastroenterology in Sheba ARC focusing on IP-driven innovation in gastrointestinal diseases.
Dr. Ayal Hirsch is a gastroenterologist in Chicago, Illinois. He received his medical degree from Technion-Israel Inst of Technology Faculty of Medicine. Dr. Hirsch’s top areas of expertise are Viral Gastroenteritis, Crohn’s Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy. His clinical research consists of co-authoring 32 peer reviewed articles. Additionally, he has co-authored 29 articles in the study of Viral Gastroenteritis.